Aromatase inhibitors such as letrozole are hypothesized to maintain normal hypothalamic pituitary feedback mechanisms, and in case of ovulation induction in women with PCOS, may act to increase follicular sensitivity to FSH through increasing intrafollicular androgen levels. The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.